Astria Therapeutics, Inc.
Astria Therapeutics, Inc. (ATXS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
atxs · stock forecast · 8 analysts (3M) · FMP · updated Feb 3, 2026
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Hold
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$26.00
Consensus
$19.40
+54.2% upside
Low
$13.00
Median: $20 · Last Close: $12.58
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$19.40
54.2% upside
High Target
$26
106.7%
Low Target
$13
3.3%
Current Price
$12.58
as of today
Based on analyst price targets, the ATXS stock price prediction for the next 12 months ranges from $13 to $26. The consensus ATXS price forecast of $19.40 implies 54.2% upside from the current price of $12.58.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $12.40 | ↓ 1.43% |
1-day model range: $12.38–$12.42. Peak: $12.42 (-1.43%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $10 | -23.9% |
| 2028 | $8 | -33.9% |
| 2029 | $8 | -38.7% |
| 2030 | $7 | -41.1% |
| 2031 | — | -42.4% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ATXS · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-12 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2025-10-16 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-10-15 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2025-10-15 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2025-10-14 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2025-09-17 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2025-09-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-06-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Astria Therapeutics, Inc. (ATXS) stock. Of the recent 49 rating actions, 0 were upgrades and 5 were downgrades. 8 analysts currently cover ATXS.
Analyst Recommendation Trends
ATXS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$16M
↑ 69.3% YoY
Revenue Next Year
$4M
↓ 75.0% YoY
EPS This Year
$-1.99
EPS Next Year
$-2.14
↑ 7.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast ATXS EPS of $-1.99 for the current fiscal year, based on estimates from 3 analysts. The ATXS revenue forecast is $16M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ATXS stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ATXS price target is $19.40 (+54.2% upside), with an analyst consensus of Hold.
The ATXS short-term stock prediction for tomorrow is $12.40 (-1.43%). The ATXS stock price prediction for 2027 estimates an average of $10. The ATXS stock prediction for 2030 projects a range of $7–$8.
Astria Therapeutics, Inc. trades on NASDAQ under the ticker ATXS. The ATXS stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 38% of covering analysts.
Frequently asked questions
ATXS forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month ATXS price target is $19.40, with a high forecast of $26.00 and a low of $13.00. The median price target is shown in the chart above when available. This implies +54.2% potential upside from the current price of $12.58.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.